Although CD8 T cell exhaustion has been well-established and considered a target of immunotherapy for cancer patients, relatively few studies have focused on the importance of PD-1 blockade for increased PD-1 expression and the functional recovery of CD4 T cells. This evidence concerns the gene CD4 and cancer.